PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 10: Articles 4501-5000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Men influence contraceptive use.
  2. Men's attitudes towards family planning: a pilot study in two communes of northern Vietnam.
  3. Men's responsibility in the Reproductive Health Program including family planning and sexual health. [Trach nhiem cua nam gioi trong chuong trinh suc khoe sinh san bao gom khhgd va suc khoe gioi tinh.]
  4. Men's role in reproductive health and family planning. [Vai tro cua nam gioi trong sinh san va ke hoach hoa gia dinh.]
  5. Men's views on male hormonal contraception -- a survey of the views of attenders at a fitness centre in Bristol, UK.
  6. Men, family planning and reproductive health in Pakistan.
  7. Meru and Kakamega: collaborators in family planning.
  8. Metabolic and endocrine effects of the desogestrel-containing oral contraceptive Mircette.
  9. Methodologic limitations in comparing the risks of newer oral contraceptives. Response.
  10. Midterm assessment of Intermediate Result 1 of Strategic Objective 3, "Increased Public Sector Provision of Family Planning and Maternal and Child Health Services".
  11. Midterm assessment of intermediate result 2 of strategic objective 3: "National systems strengthened to promote and support family planning / maternal and child health program".
  12. Midterm assessment of intermediate result 3 of strategic objective 3: "Increased private sector provision of contraceptives and family planning / maternal and child health services".
  13. Minister Zhang Weiqing on the goals of China's family planning programme.
  14. Mircette: a novel oral contraceptive. Introduction.
  15. Mircette: a novel oral contraceptive. Ovarian activity in women taking an oral contraceptive containing 20 micrograms ethinyl estradiol and 150 micrograms desogestrel: effects of low estrogen doses during the hormone-free interval.
  16. Missed opportunities: teenagers and emergency contraception.
  17. Modern contraceptive technologies and attributes: preferences of women along the U.S.-Mexico border region.
  18. Modern contraceptives. [Les contraceptifs modernes.]
  19. Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study.
  20. 10 common questions on emergency contraception.
  21. 17Beta-hydroxysteroid dehydrogenase type 1 in normal breast tissue during the menstrual cycle and hormonal contraception.
  22. 1997 contraceptive social marketing statistics.
  23. A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK.
  24. 30 years of contraception in France. [30 ans de contraception en France.]
  25. A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand.
  26. A 40-year-old woman considering contraception.
  27. Abortion and contraceptive failure.
  28. Abortion and unmet need for contraception in Tanzania -- the role of male partners in teenage induced abortion in Dar es Salaam.
  29. Abortion rate among young Romanians declines; those not in union report rise in contraceptive use.
  30. Abortion, birth control, and public policy.
  31. Accelerating India's fertility decline: the role of temporary contraceptive methods.
  32. The accessibility of contraceptives and service quality in drug stores in Shanghai.
  33. ACQUIS. Accelerating Access to Contraceptives and Quality to Increase and Improve Services. Final implementation report.
  34. Activated protein C resistance and deficiencies of antithrombin III, protein C or protein S and the risk of thromboembolic disease in users of oral contraceptives.
  35. Adolescent contraception.
  36. Adolescent satisfaction with postpartum contraception and body weight concerns.
  37. Adolescent sex and contraceptive experiences: perspectives of teenagers and clinic nurses in the Northern Province.
  38. Adverse effects associated with contraceptive implants: incidence, prevention and management.
  39. Advice on contraception for new mothers in Finland. [Synnyttaneiden ehkaisyneuvonta suomessa.]
  40. AIDS: knowledge, attitudes and sex behavior of young people attending AIED family planning health services. [AIDS: conoscenze, attitudini e comportamenti sessuali di giovani utenti dei consultori familiari AIED.]
  41. Albanian women speak about family planning.
  42. All about birth control: a personal guide.
  43. Almost one in three Ugandan births are unwanted or mistimed, but few women practice contraception.
  44. Analysis of contraceptive failure data in intrauterine device studies.
  45. Analysis of the failures of natural family planning over 7007 cycles of use. [Analyse des echecs de la planification familiale naturelle. A propos de 7 007 cycles d'utilisation.]
  46. Antenatal care and contraceptive behaviour in India: some evidence from the National Family Health Survey.
  47. Application of artificial neural networks to contraception study.
  48. Application of demographic estimation models to fertility in a Nigerian ethnic group: implications for population growth and family planning programmes.
  49. Approach towards birth control: Indian women in the early twentieth century.
  50. Approaches to the replacement of ethinylestradiol by natural 17 beta-estradiol in combined oral contraceptives.
  51. Are oral contraceptives masking symptoms of chlamydial cervicitis and pelvic inflammatory disease?
  52. Are oral contraceptives safe? [letter]
  53. Are we making progress with emergency contraception? Recent findings on American adults and health professionals.
  54. As rise in family planning use slows in Bangladesh, method mix shifts toward reversible contraception.
  55. Assessment of sub-centers in Jhansi district in preparation for clinic-based family planning (CBFP) training and upgrading.
  56. An assessment of the Zimbabwe family planning programme. Results from the 1996 situation analysis study.
  57. The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels.
  58. Attenders at young people's clinics in Southampton: variations in contraceptive use.
  59. Attitudes of men towards family planning in Mbeya region, Tanzania: a rural-urban comparison of qualitative data.
  60. Attitudes to sexuality and family planning.
  61. An audit of emergency contraception: a look at patient characteristics and the effects of a consultation proforma.
  62. Auditing the introduction of a new product to a family planning service.
  63. Awareness and use of family planning methods among married women in Ibadan, Nigeria.
  64. Baby boom. American anti-abortion politics blocks family planning funding around the world.
  65. Behavioral and neurobiological effects of estrogen replacement therapy and a history of triphasic oral contraceptive exposure.
  66. Beliefs concerning contraceptive acquisition and use among low-income women.
  67. Berlex introduces new 20 mcg birth control pill.
  68. Bias versus causality: interpreting recent evidence of oral contraceptive studies.
  69. Biological effects of eleven combined oral contraceptives on serum triglycerides, gamma-glutamyltransferase, alkaline phosphatase, bilirubin and other biochemical variables.
  70. Birth control and bureaucracy.
  71. Birth control and the black community in the 1960's: genocide or power politics?
  72. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
  73. Calcium and phosphorus in milk of Brazilian mothers using oral contraceptives.
  74. Call 1-888-NOT-2-LATE: promoting emergency contraception in the United States.
  75. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
  76. Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?
  77. Cardiovascular disease and hormonal contraceptives: latest results.
  78. Cardiovascular disease and steroid hormone contraception: report of a WHO scientific group.
  79. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
  80. Cardiovascular safety and combined oral contraceptives [editorial]
  81. Cardiovascular safety of oral contraceptives. What has changed in the last decade?
  82. Case studies in contraception.
  83. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions.
  84. Caught between teens and the law: family planning programs and statutory rape reporting.
  85. Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability [editorial]
  86. Cerebral thrombosis and oral contraceptives: a case-control study.
  87. Challenges of family planning in Africa [editorial]
  88. The changing impact of religion on the sexual and contraceptive behavior of adolescent women in the United States.
  89. Characterization of calcified deposits on contraceptive intrauterine devices.
  90. Checklist for family planning service delivery, with selected linkages to reproductive health.
  91. China's population curbed by 300 million, says Li. More men involved in family planning.
  92. Choosing contraception. [Optar por la anticoncepcion.]
  93. Client perspectives on quality of contraceptive and abortion services at three sites in Viet Nam.
  94. Client-centered communication in family planning: is it relevant for developing countries?
  95. Client-provider communication in family planning: assessing audiotaped consultations from Kenya.
  96. Clinic provision of contraceptive services to managed care enrollees.
  97. Clinic-based family planning and reproductive health programs in sub-Saharan Africa.
  98. Clinical experiences with a gestodene-containing oral contraceptive (Femoden) [Gesztoden tartalmu hormonalis fogamzasgatloval (Femoden) szerzett klinkai tapasztalatok.]
  99. Coeliac axis thrombosis associated with the combined oral contraceptive pill: a rare cause of an acute abdomen.
  100. The collection and interpretation of epidemiological data about the cardiovascular risks associated with the use of steroid contraceptives.
  101. In Colombia, the jury is still out on a key topic: family planning.
  102. Combined oral contraception and cardiovascular diseases: the end of the third generation controversy. [Contraception estroprogestative et pathologies cardio-vasculaires: la fin d'une polemique sur la troisieme generation.]
  103. Combined oral contraceptives versus levonorgestrel for emergency contraception.
  104. Combined oral contraceptives, migraine and ischaemic stroke. Recommendations for clinical practice.
  105. Combined oral contraceptives, smoking, and cardiovascular risk.
  106. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function.
  107. A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene.
  108. Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? A study of injectable and oral contraceptive use in Johannesburg.
  109. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation.
  110. Conceptions and terminations after the 1995 warning about oral contraceptives [letter]
  111. Concerns and cautions about prescribing and deregulating emergency contraception: a qualitative study of GPs using telephone interviews.
  112. Condom use among women choosing long-term hormonal contraception.
  113. Condom use by Hispanic and African-American adolescent girls who use hormonal contraception.
  114. Conducting successful focus groups and analysis: experience from a pilot study on family planning and sexual behaviour in the era of HIV / AIDS and STDs.
  115. Conference reports. Strengthening STD / HIV / AIDS work in the framework of sexual-reproductive health / family planning projects, 29 January 1998, Heidelberg.
  116. A Congressional view: access to family planning important.
  117. Consortium for Emergency Contraception.
  118. Consumer perceptions of quality of family planning services in Egypt. [Draft]
  119. Continuation of contraceptive and service use: the CSI project experience.
  120. Continuation of family planning: follow-up of public establishment users in Santa province. [Continuidad en la planificacion familiar: un seguimiento de usuarias de establecimientos publicos de la provincia de Santa.]
  121. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
  122. Contraception after heart transplantation. [Contraccezione dopo trapianto cardiaco.]
  123. Contraception and abortion in two Vietnamese communes.
  124. Contraception and culture: the use of Yuyos in Paraguay.
  125. Contraception and induced abortion in Armenia: a critical need for family planning programs in Eastern Europe.
  126. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus.
  127. Contraception as prevention and therapy: sex steroids and the brain.
  128. Contraception at age 35 years and older.
  129. Contraception during lactation: a comparison of methods.
  130. Contraception improves employment prospects.
  131. Contraception in female transplant recipients. [La contraception chez la femme transplantee.]
  132. Contraception in France: a balance-sheet after 30 years of liberalization. [La contraception en France: un bilan apres 30 ans de liberalisation.]
  133. Contraception in the patient with liver disease.
  134. Contraception in women with special medical needs.
  135. Contraception influences quality of life.
  136. Contraception per computer. Hormone system persona --results of studies in Germany. [Kontrazeption per Computer. Hormonmesssystem Persona --Studienergebnisse in Deutschland.]
  137. Contraception today. A report on the Royal Society for the Promotion of Health conference. Held on Thursday 8th October, 1998, Hamilton House, London.
  138. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
  139. Contraception, sterilisation and the mentally ill: beyond Manicheanism, some reference points.
  140. Contraception-associated menstrual problems: etiology and management.
  141. Contraception. [La contraccezione.]
  142. Contraception. Slow train gathers speed.
  143. Contraception: a review.
  144. Contraception: current and future use. Provincial data. [Contraception: utilisation actuelle et future. Donnees provinciales.]
  145. Contraceptive and therapeutic effectiveness of two low-dose ethinylestradiol and cyproterone acetate regimens in the treatment of hirsute patients.
  146. Contraceptive behaviors of young Latin American adults living in Montreal. [Les comportements contraceptifs de jeunes adultes d'origine latino-americaine vivant a Montreal.]
  147. Contraceptive choice and patient compliance. The health care provider's challenge.
  148. Contraceptive choice and reproductive health -- A survey report on reproductive health in Hunan.
  149. Contraceptive choice and reproductive health -- a survey report on reproductive health in Hunan.
  150. Contraceptive choices among Nigerian women attending an antenatal clinic.
  151. Contraceptive determinants in three leading countries.
  152. Contraceptive efficacy and acceptability of a monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 150 micrograms desogestrel in Latin-American women.
  153. Contraceptive efficacy of low doses of mifepristone.
  154. Contraceptive fact sheets. A tool for advisors in logistics. [Fiches factuelles sur les contraceptifs. Un outil pour les conseillers en logistique.]
  155. Contraceptive failure and its subsequent effects in China: a two-stage event history analysis.
  156. Contraceptive failure, contraceptive discontinuation, and resumption of contraceptive use: results from the 1995 National Survey of Family Growth.
  157. Contraceptive health risks -- women's perceptions.
  158. Contraceptive intentions and subsequent use: family planning program effects in Morocco.
  159. Contraceptive knowledge and practice of pregnant teenagers requesting termination of pregnancy in inner-city London.
  160. Contraceptive knowledge is nearly universal in Senegal, yet fewer than one in seven women use a method.
  161. Contraceptive knowledge, attitudes and use among women attending health clinics in St. Petersburg, Russian Federation.
  162. Contraceptive knowledge: development of a valid measure and survey of pill users and general practitioners.
  163. Contraceptive method choices among adolescents in a Nigerian tertiary institution.
  164. Contraceptive method-mix study in Viet Nam (results of the first survey)
  165. Contraceptive methods and utilization in Rhode Island.
  166. Contraceptive parity: it's time for action.
  167. Contraceptive potential of a mifepristone-nomegestrol acetate sequential regimen in women.
  168. The contraceptive potential of lactation for Bangladeshi women.
  169. Contraceptive practices among Palestinian refugee women using the UNRWA MCH centre at Nuzha, Jordan. [Pratiques contraceptives chez les réfugiées palestiniennes utilisant les services du centre MCH UNRWA à Nuzha, en Jordanie.]
  170. Contraceptive practices and trends in France.
  171. Contraceptive practices of women living in rural areas of Bihar.
  172. Contraceptive research and development during the fifty years of independence in India: achievements and desired goal.
  173. Contraceptive research, introduction, and use: lessons from Norplant.
  174. Contraceptive safety: rumors and realities. 2nd ed.
  175. The contraceptive self-efficacy scale: analysis in four samples.
  176. Contraceptive social marketing in Pakistan: assessing the impact of the 1991 condom price increases on sales and consumption.
  177. Contraceptive social marketing in Pakistan: trends in knowledge, access and use of condom between 1984 and 1994.
  178. Contraceptive supply and donor planning to developing countries, 1992-2004.
  179. Contraceptive supply and donor planning to developing countries, 1992-2004. Appendix D-J: Shipment analysis, donor shipment tables, Spectrum Model inputs / outputs for study countries.
  180. Contraceptive technology and family planning services.
  181. Contraceptive technology. Seventeenth revised edition.
  182. Contraceptive use among Latina women: social, cultural, and demographic correlates.
  183. Contraceptive use among married adolescent girls in rural Bangladesh.
  184. Contraceptive use and desire for more children in two rural districts of Sierra Leone.
  185. Contraceptive use and pregnancy before and after introducing lactational amenorrhea (LAM) in a postpartum program.
  186. Contraceptive use at an STD clinic in Kumasi, Ghana.
  187. Contraceptive use in a rural general practice.
  188. Contraceptive use in South Africa under apartheid.
  189. Contraceptive use: the US perspective.
  190. Contraceptives: regional perspectives, issues, and unmet needs -- the European perspective.
  191. Contribution of radio drama, Twende na Wakati, on family planning and HIV / AIDS awareness in Tanzania.
  192. Coping with birth control. Revised ed.
  193. Cost to employer health plans of co:ering contraceptives. Summary, methodology and background.
  194. Costs can influence family planning decisions.
  195. The costs of contraceptive social marketing programs implemented through the SOMARC project.
  196. Couple's reproductive decision making and contraceptive use in Osun State.
  197. Couple's reproductive decision-making and contraceptive use in Ondo State.
  198. Creating conditions for a sustainable family planning program.
  199. Creating linkages between incomplete abortion treatment and family planning services in Kenya: what works best?
  200. Current monophasic hormonal contraception. [Suvremennata monofazna khormonalna kontratseptsiia.]
  201. Current reversible contraceptive methods: a global perspective.
  202. Cutaneous malignant melanoma in women and the role of oral contraceptives.
  203. Cytomorphometric analysis of vaginal cells during normal cycle, under oral contraceptive therapy or in-vitro fertilization stimulation protocol.
  204. The Daily Mail has been trying to raise public anxiety over teenagers, sex and the contraceptive pill to reckless levels.
  205. Demand for contraception by Sahelian couples: are men's and women's expectations converging? The cases of Burkina Faso and Mali.
  206. Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents.
  207. Depressive symptoms and Norplant contraceptive implants.
  208. Descriptions of the family planning programs studied.
  209. Determinants of contraceptive use among married teenage women and newlywed couples.
  210. Determinants of family planning and use of ASHONPLAFA services. Results of the baseline survey, 1996. [Determinantes de planificacion familiar y uso de servicios de ASHONPLAFA: resultados de la encuesta de base, 1996.]
  211. Determinants of quality of family planning services: a case study of Kenya.
  212. Developing and testing approaches for improving method mix in family planning programs in Bolivia. Project code: No. 0350-04075. Project period: June-September 1998.
  213. Development of support material for policy improvement and service expansion in natural family planning. Project code No. 350-04080. Project period: June-September, 1998.
  214. Diagnostic study of the experience oF RENAFE-MOB in mainstreaming natural family planning services with the Ministry of Health and Save the Children in Honduras. Project code: No. 0350-04081. Project period: June-September 1998.
  215. Different nocturnal body temperatures and sleep with forced-air warming in men and women taking hormonal contraceptives.
  216. Disagreement in spousal reports of current contraceptive use in Sub-Saharan Africa.
  217. Discussion -- Meeting contraceptive needs worldwide: the role of monthly combined injectables.
  218. Dispensation of emergency contraceptive pills in Michigan Title X clinics.
  219. Dissemination workshop on "Assessing the Quality of Family Planning and Selected Reproductive Health Services".
  220. Does the timing of the first family planning visit still matter?
  221. DOH backs out of family planning conference.

     

  222. Domestic, international family planning programs at risk.
  223. Donor support for contraceptive commodities, 1996.
  224. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms / day or levonorgestrel 30 micrograms / day. Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill.
  225. Drug interaction and oral contraception. [Interaction medicamenteuse et contraception orale.]
  226. Dual contraceptive use among culturally diverse women at risk of HIV.
  227. Emergency contraception among refugees and the displaced.
  228. Emergency contraception as an element of care for rape victims. [La anticoncepcion de emergencia como elemento de la atencion a victimas de violacion.]
  229. Emergency contraception for midwifery practice.
  230. Emergency contraception for midwifery practice. Response [letter]
  231. Emergency contraception gains momentum in U.S.
  232. Emergency contraception given without prescription used safely and correctly.
  233. Emergency contraception in Ecuador and Mexico. [Anticoncepción de emergencia en Ecuador y México.]
  234. Emergency contraception in Nigeria. Report of an exploratory research.
  235. Emergency contraception in Zambia: setting a new agenda for research and action.
  236. Emergency contraception status report: work to do.
  237. Emergency contraception update.
  238. Emergency contraception use and the evaluation of barrier contraceptives. New challenges for study design, implementation, and analysis.
  239. Emergency contraception with levonorgestrel or the Yuzpe regimen.
  240. Emergency contraception: a brighter future?
  241. Emergency contraception: a cost-effective approach to preventing unintended pregnancy.
  242. Emergency contraception: a global overview.
  243. Emergency contraception: a guide for service delivery.
  244. Emergency contraception: a modality whose time has come [editorial]
  245. Emergency contraception: an option for women's empowerment.
  246. Emergency contraception: not a secret any more.
  247. Emergency contraception: preliminary report of a demonstration and evaluation project.
  248. Emergency contraception: the user profile.
  249. Emergency contraception: the users and the services.
  250. Emergency contraception: WHO Task Force study [letter]
  251. Emergency contraceptive pills: an exploratory study of knowledge and perceptions among Mexican women from both sides of the border.
  252. Emergency contraceptive pills: an exploratory study of knowledge and perceptions among Mexican women from both sides of the border.
  253. Emergency contraceptive pills: an important option for young adults.
  254. Emergency contraceptive pills: information package for health providers and program directors. [Pildoras anticonceptivas de emergencia. Paquete informativo para proveedores de salud y directores de programas.]
  255. Emergency contraceptive pills: what does the law say about prescribing, dispensing, repackaging, and advertising?
  256. Emergency contraceptive pills: what you need to know. Brochure for programs providing combined ECPs.
  257. Emergency postcoital contraception [letter]
  258. Emergency postcoital contraception.
  259. Enhancing the role of men in family planning and reproductive health.
  260. Environmental groups support Japan's ban on oral contraceptive.
  261. Epidemiology of oral contraceptives and cardiovascular disease.
  262. Erap position on family planning cited.
  263. Erap shuns birth control, bats for "responsible parenthood".
  264. Eros's illness. A complex net of abortions, STD and contraceptive agents. [Eros' ohalsa. Komplex vav av aborter, STD och preventivmedel.]
  265. Ethnic differences in testicular structure and spermatogenic potential may predispose testes of Asian men to a heightened sensitivity to steroidal contraceptives.
  266. Eugenics, contraception, abortion and ethics [editorial]
  267. Evaluating family planning costs. Introduction.
  268. Evaluation of sexually transmitted diseases diagnostic algorithms among family planning clients in Dar es Salaam, Tanzania.
  269. Evaluation of the contraceptive potential of recombinant human ZP3 and human ZP3 peptides in a primate model: their safety and efficacy.
  270. Evaluation of the pre-introduction of contraception by means of subcutaneous levonorgestrel implants in Burkina Faso. [Evaluation de la pre-introduction de la contraception par les implants sous-cutanes de levonorgestrel au Burkina Faso.]
  271. The evolution and role of family planning programs in fertility change in Kenya.
  272. Evolution of China's family planning policy and fertility transition.
  273. Exacerbation of premenstrual asthma caused by an oral contraceptive.
  274. Expand male contraceptive services by offering no-scalpel vasectomies.
  275. Expanding options, improving access. Natural family planning and reproductive health awareness.
  276. Expansion of the role of auxiliary nursing personnel in family planning service delivery and performing cytologic tests. Final report. [Expansion del rol del personal auxiliar de enfermeria en la prestacion de servicios de planificacion familiar y toma de citologia. Informe final.]
  277. Experiences in the diffusion of emergency contraception in Latin America.
  278. An exploration of the discursive constructions used in young adults' memories and accounts of contraception.
  279. Factor V Leiden and pulmonary embolism in a young woman taking an oral contraceptive.
  280. Factors affecting family planning drop-out rates.
  281. Factors affecting the outputs and costs of community-based distribution of family planning services in Tanzania.
  282. Factors determining the choice of contraceptive methods at the Family Planning Clinic, University College Hospital, Ibadan, Nigeria.
  283. Factors influencing male interest in family planning in Kenya.
  284. Family life education increases contraceptive knowledge and use by Mexican youth. [La educación familiar aumenta el conocimiento y el uso de los anticonceptivos en la juventud mexicana.]
  285. Family planning -- under duress. [Familieplanlegging -- under tvang.]
  286. Family planning and HIV / AIDS in sub-Saharan Africa: challenges and strategies.
  287. Family planning and HIV / AIDS: what are the concerns?
  288. Family planning and its effects on the lives of women in China.
  289. Family planning and population programs in Colombia, 1965 to 1997.
  290. Family planning and procedure manual for nurses.
  291. Family planning and reproductive health clinical procedure manual for physicians.
  292. Family planning and reproductive health in Yopougon (Ivory Coast): survey methodology. [Planification familiale et sante de la reproduction a Yopougon (Cote-d'Ivoire): methodologie de l'enquete.]
  293. Family planning and social contexts. [Planeamento familiar e contextos sociais.]
  294. Family planning and target-setting.
  295. Family planning and women's lives: a synthesis of findings.
  296. Family Planning Association of Castille and Leon. [Asociacion de Planificacion Familiar de Castilla y Leon.]
  297. Family planning associations (FPAs) respond to the HIV / AIDS epidemic.
  298. Family planning at heart of political debate.
  299. Family planning campaign: the case in Masaka district, Uganda.
  300. Family planning camps as an opportunity to assess and help reduce the prevalence of reproductive health morbidities in rural Nepal.
  301. Family planning enhances women's status.
  302. Family planning for new mothers in the Philippines.
  303. Family planning for women with learning disabilities.
  304. Family planning in China: out of control?
  305. Family planning in developing countries: an unfinished success story.
  306. Family planning in Taiwan.
  307. Family planning knowledge, attitudes and practices in women with schizophrenic spectrum disorders.
  308. Family planning knowledge, attitudes and public advocacy: findings from the 1997 survey of Muslim religious leaders in Jordan. Final report.
  309. Family planning offered in local welfare offices.
  310. Family planning policies and programmes in eight low-income countries: a comparative policy analysis.
  311. Family planning practice in Morocco: 200 laparoscopic tubal ligation cases by Yoon ring. [Pratique de la regulation des naissances au Maroc. A propos de 200 cas de ligatures tubaires coelioscopiques par anneaux de Yoon.]
  312. Family planning practices in Morocco. 200 laparoscopic Yoon ring tubal ligations. [Pratique de la regulation des naissances au Maroc. A propos de 200 cas de ligatures tubaires coelioscopiques par anneaux de Yoon.]
  313. Family planning promotion in HIV infected Zambians.
  314. Family planning providers losing ground on salary front. 1998 salary survey results.
  315. Family planning service provision in rural areas: a survey in Washington state.
  316. Family planning survey of floating population in Zhejiang.
  317. Family planning use often a family decision.
  318. Family planning's role in reducing health risks.
  319. Family planning, fertility control and the law in Nigeria -- the choices for a new century.
  320. Family planning, maternal / child health, and sexually-transmitted diseases in Tanzania: multivariate results using data from the 1996 Demographic and Health Survey and Service Availability Survey.
  321. Family planning. [Planification familiale.]
  322. Family planning. [Planification familiale.]
  323. Family planning: programmes and people [editorial]
  324. Family size preferences and attitudes towards contraceptive use among men: the case of Kaptumo community in Nandi district of Kenya. An analysis of patriarchal implications on fertility regulation.
  325. Family size preferences and attitudes towards contraceptive use among men: the case of Kaptumo community in Nandi district of Kenya. An analysis of patriarchal implications on fertility regulation. Summary report.
  326. FDA approves emergency contraception kit.
  327. Fees for other services help pay for family planning.
  328. The FemCap: a new contraceptive choice.
  329. Fertility and contraception in end-stage renal disease.
  330. Fertility and family planning among Jenu Kuruba and Kadu Kuruba tribes of Karnataka.
  331. Fertility attitudes and family planning practices of men in a rural community of Maharashtra.
  332. Final report: project assessment and dissemination conference preparation. Collaborative Family Planning and Reproductive Health Services Development Project, Novosibirsk oblast and Primorsky krai, Russia.
  333. Finnish health centre physicians' participation in family planning [letter]
  334. First emergency contraceptive product hits U.S. market shelves.
  335. First Lady's World Health Day speech. Family planning helps ensure safe motherhood.
  336. Flexible starting schedule for oral contraception: effect on the incidence of breakthrough bleeding and compliance.
  337. Follow-up assessment of the Indian Medical Association (IMA) family planning clinical training course in Gujarat.
  338. Follow-up of family planning clinical service providers in Tanzania.
  339. Follow-up on training of indigenous systems of medicine practitioners in non-clinical methods of family planning in Uttar Pradesh, India.
  340. Four approaches to emergency contraception in Ecuador. The Population Council, INOPAL III final draft report.
  341. From compliance to concordance: a challenge for contraceptive prescribers.
  342. From family planning to reproductive health.
  343. From family planning to reproductive health: emerging issues in informed choice.
  344. The future of contraception.
  345. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
  346. Gap between knowledge and practice of family planning method among currently married women in U.P.
  347. Gender analysis of family planning. Beyond the 'feminist vs. population control' debate.
  348. Gender, menstrual cycle, oral contraceptives and red blood cell deformability in healthy adult subjects.
  349. Genital chlamydial disease in an urban, primarily Hispanic, family planning clinic.
  350. Genital infections among women using various contraceptive methods in Basra, Iraq. [Infections génitales chez les femmes utilisant diverses méthodes contraceptives à Basra, en Irak.]
  351. Gestodene and desogestrel do not have a different influence on concentration profiles of ethinylestradiol in women taking oral contraceptives -- results of isotope dilution mass spectrometry measurements.
  352. Getting from awareness to use: lessons learned from SOMARC III about marketing hormonal contraceptives.
  353. Getting men involved in family planning. Experiences from an innovative program. Final report.
  354. In Ghana and Kenya, many spouses disagree on their need for contraception.
  355. GPs, schoolgirls and sex. A cross cultural background comparison of general practitioner attitudes towards contraceptive service provision for young adolescent females in Scotland.
  356. Guidelines for clinical procedures in family planning. A reference for trainers. Annex 11. Infection prevention in MCH / FP centers. Revised ed. [Lignes directrices pour les procedures cliniques en planification familiale: une reference pour les formateurs. Annexe 11. Prevention de l'infection dans les centres de SMI/PF. Edition revisee en mai 1998.]
  357. Guidelines require comprehensive steps. Effective use of national family planning guidelines includes dissemination and regular updating.
  358. Gynetics, Inc., to market emergency contraceptive pills.
  359. Handling the conflict. Many priests all over the world will still go on bending the rules against the use of artificial contraceptives with compassion.
  360. Headache, migraine and oral contraceptives.
  361. Hemorrhage caused by ruptured liver cell adenoma following long-term oral contraceptives: a case report.
  362. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
  363. Heterosexual transmission of human immunodeficiency virus type 1 (HIV): interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1.
  364. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
  365. HIV infection among family planning clinic attenders in Glasgow: why prevalence has remained low in this general population group.
  366. Hormonal choices after gestational diabetes. Subsequent pregnancy, contraception, and hormone replacement.
  367. Hormonal contraception and genital-tract shedding of HIV-1-infected cells [letter]
  368. Hormonal contraception and genital-tract shedding of HIV-1-infected cells. Authors' reply [letter]
  369. Hormonal contraception and risk of cardiovascular disease: an international perspective.
  370. Hormonal contraception and the skin.
  371. Hormonal contraception in the diabetic woman. [La contraception hormonale chez la femme diabetique.]
  372. Hormones and cardiovascular diseases: oral contraceptives and hormonal replacement therapy: differential effects on coronary heart disease, deep venous thrombosis and stroke.
  373. Household expenditure and the utilization of family planning and maternal health services in Indonesia.
  374. How family planning use affects women's lives.
  375. How providers restrict access to family planning methods: results from five African countries.
  376. How relationships of U.S. men affect contraceptive use and efforts to prevent sexually transmitted diseaes.
  377. How to talk to young people about contraception. [Miten puhua nuorille ehkaisysta.]
  378. Human rights trends and coercive family planning in the PRC.
  379. The husband's role in determining whether contraception is used: the influence of gender context in five Asian countries.
  380. Identification of choriocarcinoma by the hCG Beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use.
  381. IEC, family planning, and STD interventions: shifting to a reproductive and sexual health perspective.
  382. Ileal penetration by a Multiload-Cu 375 intrauterine contraceptive device. A case report with review of the literature.
  383. Immature spermatids are not prevalent in semen from men who are receiving androgen-based contraceptive regimens.
  384. The impact of a family planning multimedia campaign in Bamako, Mali.

     

  385. The impact of family planning household service delivery on women's status in Bangladesh.
  386. The impact of intrauterine contraceptive devices on cytological findings from routine pap smear testing.
  387. The impact of patient experience on practice: the acceptability of emergency contraceptive pills in inner-city clinics.
  388. Impact of socio-economic development on family planning performance in Andhra Pradesh during 1991.
  389. The impact of type of employment on women's use of prenatal-care services and family planning in urban Cebu, the Philippines.
  390. The importance of subsequent contraception in reducing unwanted pregnancies. [Jalkiehkaisylla tarkea sija ei-toivottujen raskauksien vahentamisessa.]
  391. Improving access to contraception: a plan for action. [Information packet]
  392. Improving contraceptive access for teens.
  393. Improving patient success with oral contraceptives: the importance of counseling.
  394. Improving quality and use of family planning in three sites in Viet Nam.
  395. Improving the quality of services in the private sector: doctors as family planning providers in Pakistan.
  396. Improving women's access to emergency contraception: innovative information and service delivery strategies.
  397. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania.
  398. Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives [letter]
  399. Increasing access to combination oral contraceptives.
  400. Increasing access to contraceptives: on the map and in the bag.
  401. Increasing Access to Emergency Contraception in Latin America, regional workshop, Quito, Ecuador, April 27-29, 1998. [Ampliando el Acceso a la Anticoncepcion de Emergencia en America Latina, taller regional, Quito, Ecuador, Abril 27-29, 1998.]
  402. Increasing barrier method use among oral contraceptive users at risk of STDs. What approach is best?
  403. Increasing the effectiveness of contraceptive usage in university students.
  404. Increasing the use of reproductive health services in a family planning clinic. [Incrementando la utilizacion de servicios de salud reproductiva en una clinica de planificacion familiar.]
  405. Influence of hormonal contraceptives on microbial flora of gingival sulcus.
  406. The influence of oral contraceptives on the risk of multiple sclerosis.
  407. Information map: population, family planning and prosperous family. [Peta informasi: kependudukan, keluarga berencana dan keluarga sejahtera.]
  408. Information strategies for emergency contraception. [Estrategias de informacion sobre anticoncepcion de emergencia.]
  409. Informed choice and informed consent in the USAID international family planning program. Text of message from USAID administrator, J. Brian Atwood, to all USAID staff, May 14, 1998.
  410. Informed choice in family planning: legacies and challenges.
  411. Informed consent among acceptors of contraceptive methods after an obstetric event. INOPAL III final technical report.
  412. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
  413. Inner-city adolescents' awareness of emergency contraception.
  414. Instituto Mexicano de Investigacion en Familia y Poblacion, IMIFAP. Operations research final report presented to INOPAL III / the Population Council. Testing Strategies to Disseminate Knowledge of Emergency Contraception (Subaward No. CI97.09)
  415. Integrating STI and HIV / AIDS services at MCH / family planning clinics.
  416. Integration of family planning / MCH with HIV / STD prevention. Programmatic technical guidance. Priority for primary prevention with a focus on high transmitters.
  417. The integration of family planning and development activities in India.
  418. International obstetric care project: operations research and technical assistance on linkages between emergency obstetric care and family planning in Latin America and the Caribbean (LAC). Sub-project contract number CI95.34A. Sub-project Dates: July 1, 1995 - September 30, 1998. Final report.
  419. Internet opens access to contraceptive methods.
  420. Interpersonal communication / counseling: self-assessment and peer review interventions for family planning providers in Indonesia. Operations research [abstract]
  421. Intrauterine contraception.
  422. Intrauterine contraception: will progress come where we are expecting it. [Contraception intra-uterine: le progres viendrait-il de la ou on l'attend?]
  423. Introducing more contraceptive methods in Jordan.
  424. Introduction of Cyclofem once-a-month injectable contraceptive in Mexico.
  425. Involving men in family planning. [Involucrar a los hombres en la planificacion familiar.]
  426. Involving private medical practitioners in family planning services. Final report.
  427. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.
  428. Is endometrial ablation a safe contraceptive method? Pregnancy following endometrial ablation.
  429. Is low income a constraint to contraceptive use among the Pakistani poor?
  430. Is vasectomy of long-term benefit? Vasectomy: an effective form of contraception.
  431. Islamic manual of family planning, 1998.
  432. IUD update signals renaissance for long-term contraceptive method.
  433. Kallikrein concentration in mixed saliva after contraceptive administration or postmenopausal hormone replacement. [Zur Kallikreinkonzentration im Vollspeichel nach Kontrazeptivagabe oder postmenopausaler Hormonsubstitution.]
  434. Knowledge and perceptions of reproduction and contraception in an informal settlement in Gauteng [letter]
  435. Knowledge and use of contraceptive methods by the female population in one health-care district. [Conocimiento y uso de metodos anticonceptivos por la poblacion femenina de una zona de salud.]
  436. Knowledge and use of emergency contraception amongst Nigerian undergraduates.
  437. Knowledge, attitude and behaviour towards small family norm and contraceptive use: a micro level study.
  438. Knowledge, attitudes and practices of health workers in the city of Marikina with regards [to] the use of natural family planning methods.
  439. Lactation-induced amenorrhea as birth control method. [Lactatieamenorroe als geboorteregelingsmethode.]
  440. Lactational amenorrhea as a birth control method (letter) [Lactatieamenorroe als geboorteregelingsmethode.]
  441. Lactational amenorrhea as a contraceptive method. [Lactatieamenorroe als geboorteregelingsmethode.]
  442. Lactational amenorrhea method provides effective postpartum contraception.
  443. Legitimate recuperation or illicit stalling? Time, contraceptive use, and the divided man in rural Gambia.
  444. Level of contraceptive use is moderate among Romanians aged 15-24.
  445. Levels of unwanted childbearing are high in Nepal, where only one in three women use contraceptives.
  446. Levonorgestrel contraceptive implants in female patients 14 to 21 years old.
  447. Literacy and family planning education in rural Ghana.
  448. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
  449. Low-dose oestrogen oral contraceptives do not increase heart-attack risk.
  450. Mainstreaming contraceptive services in managed care -- five states' experiences.
  451. Major contraceptive study begins. Press release.
  452. Making informed choices about combined oral contraceptives.
  453. Male contraception in Nigeria: differentials, patterns, and motivation for condom use.
  454. Monitoring contraception in an informal settlement in South Africa [letter]
  455. Myocardial infarction and stroke in young women: what is the impact of oral contraceptives?
  456. Myocardial infarction and use of low-dose oral contraceptives. A pooled analysis of 2 US studies.
  457. The national family planning movement through charts and pictures, 1997/1998. [Gerakan keluarga berencana nasional dalam grafik dan gambar, 1997/1998.]
  458. National logistics management handbook for medications: contraceptives. [Manuel national de gestion logistique des medicaments: cas des contraceptifs.]
  459. National standards of practice for family planning and reproductive health clinical services delivery.
  460. Natural contraception -- a real option? [Luomuehkaisy, onko se todellinen vaihtoehto?]
  461. The natural way. Family planning.
  462. The need for and cost of mandating private insurance coverage of contraception.
  463. New developments and practice guidelines: oral contraceptives and intrauterine devices. Introduction.
  464. New developments in contraception: what's happening.
  465. New estimates of the effectiveness of the Yuzpe regimen of emergency contraception.
  466. New once-a-month injectable contraceptives, with particular reference to Cyclofem / Cyclo-Provera.
  467. Newer oral contraceptives and the risk of venous thromboembolism.
  468. No interaction between ciprofloxacin and an oral contraceptive.
  469. Norplant as a contraceptive device in Enugu, Eastern Nigeria.
  470. Norplant subcutaneous implant contraception: 300 cases. [Contraception par les implants sous-cutanes Norplant. A propos de 300 cas.]
  471. Nutritional and psychological status of young women after a short-term use of a triphasic contraceptive steroid preparation.
  472. Obstacles to condom use: the combination of other forms of birth control and short-term monogamy.
  473. Obstacles to quality of care in family planning and reproductive health services in Tanzania.
  474. Of "condoms and cabbages": communication for population and family planning.
  475. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
  476. On-the-job training through follow-up visits to improve the quality of family planning services.
  477. An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive.
  478. Operations and other types of research in Taiwan's family planning history.
  479. Operations research in family planning and reproductive health. [Investigacion operativa en planificacion familiar y salud reproductiva.]
  480. Oral contraception and eye disease: findings in two large cohort studies.
  481. Oral contraception and factor V Leiden mutation in relation to localization of deep vein thrombosis.
  482. Oral contraception and health [editorial]
  483. Oral contraception and health: what do GPs monitor? [letter]
  484. Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study.
  485. Oral contraception was not associated with venous thromboembolic disease in recent study [letter]
  486. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons.
  487. Oral contraceptive estrogen dose considerations.
  488. An oral contraceptive for men. When will it become available? [Den mannlige p-pillen -- nar kommer den?]
  489. Oral contraceptive intake in women with focal nodular hyperplasia of the liver.
  490. Oral contraceptive use and benign gynecologic conditions. A review.
  491. Oral contraceptive use and myocardial infarction.
  492. Oral contraceptive use and risk of colorectal cancer.
  493. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease.
  494. Oral contraceptive use before and after the latest pill scare in the Netherlands. Changes in oral contraceptive use and how users change.
  495. Oral contraceptive use in relation to smoking.
  496. Oral contraceptive use: interview data versus pharmacy records.
  497. Oral contraceptives and arterial and venous thrombosis: a clinician's formulation.
  498. Oral contraceptives and breast cancer -- a causal relationship? [Orale Kontrazeptiva und Brustkrebs -- ein kausaler Zusammenhang?]
  499. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
  500. Oral contraceptives and colorectal tumors. A review of epidemiological studies.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.